Amlodipine Impurity 41 | CAS 39562-06-6 - Request Quote
Amlodipine Impurity 41
| SZ CAT No: | SZ-A005087 |
| CAS No | 39562-06-6 |
| Mol.F. | C18H20ClNO4 |
| Mol.Wt. | 349.8 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Amlodipine Impurity 41 is chemically 3-Ethyl 5-methyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate. Amlodipine Impurity 41 is supplied with detailed characterization data compliant with regulatory guideline. Amlodipine Impurity 41 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Amlodipine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 39562-06-6
Purchase 39562-06-6
Order 39562-06-6
Enquire 39562-06-6
price of 39562-06-6
39562-06-6 Supplier
39562-06-6 Manufacturer
39562-06-6 Exporter
buy high quality Amlodipine Impurity 41
Purchase Amlodipine Impurity 41
Amlodipine Impurity 41 suppliers
Amlodipine Impurity 41 manufacturers
Amlodipine Impurity 41 price
Order Amlodipine Impurity 41
Enquire Amlodipine Impurity 41
Amlodipine Impurity 41 cost
Amlodipine Impurity 41 Supplier
Amlodipine Impurity 41 Distributor
Amlodipine Impurity 41 for Method Validation
Amlodipine Reference Standard
Amlodipine Impurity 41 for ANDA Filing
Amlodipine Impurity 41 for Forced Degradation Studies
Amlodipine Impurity 41 Identification Standards
Amlodipine Impurity 41 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.